The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension.

Saved in:
Bibliographic Details
Title: The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension.
Authors: Groth SL; Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: sylviagroth@gmail.com., Newcomb CW; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Yang W; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania., Payal A; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts; The Tampa Bay Uveitis Center, St. Petersburg, Florida., Begum H; Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland., Khachatryan N; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania., Kaçmaz RO; Santen Inc., Emeryville, California., Dreger KA; Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Rosenbaum JT; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Department of Medicine, Oregon Health and Science University, Portland, Oregon; Legacy Devers Eye Institute, Portland, Oregon., Sen HN; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland., Suhler EB; Department of Medicine, Oregon Health and Science University, Portland, Oregon; Legacy Devers Eye Institute, Portland, Oregon., Thorne JE; Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Bhatt NP; Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Foster CS; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Jabs DA; Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Levy-Clarke GA; The Tampa Bay Uveitis Center, St. Petersburg, Florida; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland., Buchanich JM; Center for Occupational Biostatistics and Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania., Ying GS; Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Kempen JH; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; Department of Ophthalmology and Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Addis Ababa University School of Medicine, Addis Ababa, Ethiopia; MCM Eye Unit; MyungSung Christian Medical Center (MCM) Comprehensive Specialized Hospital and MyungSung Medical College, Addis Ababa, Ethiopia., Gangaputra S; Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee.
Corporate Authors: Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group
Source: Ophthalmology. Glaucoma [Ophthalmol Glaucoma] 2025 Nov-Dec; Vol. 8 (6), pp. 580-588. Date of Electronic Publication: 2025 May 22.
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101730510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-4196 (Electronic) Linking ISSN: 25894196 NLM ISO Abbreviation: Ophthalmol Glaucoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-4196
DOI:10.1016/j.ogla.2025.05.004